Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
about
Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there?Curbing the hepatitis C virus epidemic in Pakistan: the impact of scaling up treatment and prevention for achieving elimination.Policy responses to hepatitis C in the Nordic countries: Gaps and discrepant reporting in the Hep-Nordic study.Estimating the scale of chronic hepatitis C virus infection in the EU/EEA: a focus on migrants from anti-HCV endemic countries.Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of key populations in Barcelona, Spain.Response to Liu et al.Active Case Finding for Communicable Diseases in Prison Settings: Increasing Testing Coverage and Uptake Among the Prison Population in the European Union/European Economic Area.Approaches for simplified HCV diagnostic algorithms.Is hepatitis C virus elimination possible among people living with HIV and what will it take to achieve it?The need for a European hepatitis C programme monitoring resistance to direct-acting antiviral agents in real life to eliminate hepatitis CDisease burden of hepatitis C in the Austrian state of Tyrol - Epidemiological data and model analysis to achieve elimination by 2030Strategies for achieving viral hepatitis C micro-elimination in the NetherlandsHepatitis C virus prevention and care for drug injectors: the French approachPopulation Health and Cost-Effectiveness Implications of a "Treat All" Recommendation for HCV: A Review of the Model-Based EvidenceEpidemiology and Elimination of HCV-Related Liver DiseaseThe Effectiveness and Cost-Effectiveness of Hepatitis C Screening for Migrants in the EU/EEA: A Systematic ReviewDevelopment and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virusPatients with chronic hepatitis C receiving sofosbuvir and ribavirin-based treatment, with or without interferon in Zhejiang, China: An observational study
P2860
Q40092669-AB62066D-3015-4C0B-ABAE-E491A53A669AQ47197986-8E80AB65-6F4D-4064-A152-6B781B225528Q47547903-133A4785-4D73-489E-BC19-DEDE29366694Q47552988-B49BC464-CF4E-40C4-B33E-26AFD60B2B95Q47605695-0BFC25BF-C34A-412D-AC00-DDE827B93A11Q50131580-78F8CDD3-A89C-4165-A673-70D32C785C77Q52317642-EAEE9970-8908-45C6-B32D-F7CB9A422292Q52597014-7D6A15AC-7FC6-492F-AF1B-FC701E0EC53DQ52597017-B1F37A0F-E735-4180-B590-34311755E6FAQ56830533-5B81D575-7A91-4E66-9884-DDC013FE5F86Q56889718-E32776E1-3DA4-48EA-BDA9-001D45CA99B9Q57064977-3D45D36F-74BF-462A-ADD7-71EA3FF4B70EQ57144432-90F3CF7C-CEC7-454B-8D40-F09A0A8185F5Q57145115-4D08AF63-8C35-4032-81A9-E5EF1F790351Q57297223-0397288E-1F0D-4E49-9DB3-4DBEA2762F14Q57307361-7A21B5AF-4D50-41F4-8F41-AEB7BBAA5AE2Q58324352-4D454495-1837-4F56-9761-ED17ACDFC76FQ58704580-F95EE758-C4C6-4709-837F-FF3A64B4C9B7
P2860
Hepatitis C virus prevalence and level of intervention required to achieve the WHO targets for elimination in the European Union by 2030: a modelling study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Hepatitis C virus prevalence a ...... on by 2030: a modelling study.
@en
type
label
Hepatitis C virus prevalence a ...... on by 2030: a modelling study.
@en
prefLabel
Hepatitis C virus prevalence a ...... on by 2030: a modelling study.
@en
P1476
Hepatitis C virus prevalence a ...... on by 2030: a modelling study.
@en
P2093
European Union HCV Collaborators
P304
P356
10.1016/S2468-1253(17)30045-6
P577
2017-03-15T00:00:00Z